Based on the average brokerage recommendation (ABR), Celsius (CELH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Celsius expects core-brand pressure to persist in Q3 before growth returns exiting 2026, as SKU resets, retail gains and 2027 innovation shape recovery.
New York Times (NYT) delivered earnings and revenue surprises of +2.99% and +1.94%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
JBS N.V. (JBS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Celsius (CELH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
COCO's everyday hydration appeal, Copra acquisition and international growth support its outlook, while margin normalization and capacity needs remain key risks.
Vita Coco's raised 2026 outlook reflects strong brand demand, international growth and Copra, but valuation and second-half cost pressures temper the bullish case.